Cargando…

Moderate Binding between Two SARS-CoV-2 Protein Segments and α-Synuclein Alters Its Toxic Oligomerization Propensity Differently

[Image: see text] The neurological symptoms of long COVID and viral neuroinvasion have raised concerns about the potential interactions between SARS-CoV-2 protein segments and neuronal proteins, which might confer a risk of post-infection neurodegeneration, but the underlying mechanisms remain uncle...

Descripción completa

Detalles Bibliográficos
Autores principales: Mesias, Vince St. Dollente, Zhu, Hongni, Tang, Xiao, Dai, Xin, Liu, Wei, Guo, Yusong, Huang, Jinqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2022
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9662073/
https://www.ncbi.nlm.nih.gov/pubmed/36354180
http://dx.doi.org/10.1021/acs.jpclett.2c02278
_version_ 1784830612620705792
author Mesias, Vince St. Dollente
Zhu, Hongni
Tang, Xiao
Dai, Xin
Liu, Wei
Guo, Yusong
Huang, Jinqing
author_facet Mesias, Vince St. Dollente
Zhu, Hongni
Tang, Xiao
Dai, Xin
Liu, Wei
Guo, Yusong
Huang, Jinqing
author_sort Mesias, Vince St. Dollente
collection PubMed
description [Image: see text] The neurological symptoms of long COVID and viral neuroinvasion have raised concerns about the potential interactions between SARS-CoV-2 protein segments and neuronal proteins, which might confer a risk of post-infection neurodegeneration, but the underlying mechanisms remain unclear. Here, we reported that the receptor-binding domain (RBD) of the spike protein and the nine-residue segment (SK9) of the envelope protein could bind to α-synuclein (αSyn) with K(d) values of 503 ± 24 nM and 12.7 ± 1.6 μM, respectively. RBD could inhibit αSyn fibrillization by blocking the non-amyloid-β component region and mediating its antiparallel β-sheet structural conversions. Omicron-RBD (BA.5) was shown to have a slightly stronger affinity for αSyn (K(d) = 235 ± 10 nM), which implies similar effects, whereas SK9 may bind to the C-terminus which accelerates the formation of parallel β-sheet-containing oligomers and abruptly increases the rate of membrane disruption by 213%. Our results provide plausible molecular insights into the impact of SARS-CoV-2 post-infection and the oligomerization propensity of αSyn that is associated with Parkinson’s disease.
format Online
Article
Text
id pubmed-9662073
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher American Chemical Society
record_format MEDLINE/PubMed
spelling pubmed-96620732022-11-14 Moderate Binding between Two SARS-CoV-2 Protein Segments and α-Synuclein Alters Its Toxic Oligomerization Propensity Differently Mesias, Vince St. Dollente Zhu, Hongni Tang, Xiao Dai, Xin Liu, Wei Guo, Yusong Huang, Jinqing J Phys Chem Lett [Image: see text] The neurological symptoms of long COVID and viral neuroinvasion have raised concerns about the potential interactions between SARS-CoV-2 protein segments and neuronal proteins, which might confer a risk of post-infection neurodegeneration, but the underlying mechanisms remain unclear. Here, we reported that the receptor-binding domain (RBD) of the spike protein and the nine-residue segment (SK9) of the envelope protein could bind to α-synuclein (αSyn) with K(d) values of 503 ± 24 nM and 12.7 ± 1.6 μM, respectively. RBD could inhibit αSyn fibrillization by blocking the non-amyloid-β component region and mediating its antiparallel β-sheet structural conversions. Omicron-RBD (BA.5) was shown to have a slightly stronger affinity for αSyn (K(d) = 235 ± 10 nM), which implies similar effects, whereas SK9 may bind to the C-terminus which accelerates the formation of parallel β-sheet-containing oligomers and abruptly increases the rate of membrane disruption by 213%. Our results provide plausible molecular insights into the impact of SARS-CoV-2 post-infection and the oligomerization propensity of αSyn that is associated with Parkinson’s disease. American Chemical Society 2022-11-10 2022-11-17 /pmc/articles/PMC9662073/ /pubmed/36354180 http://dx.doi.org/10.1021/acs.jpclett.2c02278 Text en © 2022 The Authors. Published by American Chemical Society https://creativecommons.org/licenses/by-nc-nd/4.0/Permits non-commercial access and re-use, provided that author attribution and integrity are maintained; but does not permit creation of adaptations or other derivative works (https://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Mesias, Vince St. Dollente
Zhu, Hongni
Tang, Xiao
Dai, Xin
Liu, Wei
Guo, Yusong
Huang, Jinqing
Moderate Binding between Two SARS-CoV-2 Protein Segments and α-Synuclein Alters Its Toxic Oligomerization Propensity Differently
title Moderate Binding between Two SARS-CoV-2 Protein Segments and α-Synuclein Alters Its Toxic Oligomerization Propensity Differently
title_full Moderate Binding between Two SARS-CoV-2 Protein Segments and α-Synuclein Alters Its Toxic Oligomerization Propensity Differently
title_fullStr Moderate Binding between Two SARS-CoV-2 Protein Segments and α-Synuclein Alters Its Toxic Oligomerization Propensity Differently
title_full_unstemmed Moderate Binding between Two SARS-CoV-2 Protein Segments and α-Synuclein Alters Its Toxic Oligomerization Propensity Differently
title_short Moderate Binding between Two SARS-CoV-2 Protein Segments and α-Synuclein Alters Its Toxic Oligomerization Propensity Differently
title_sort moderate binding between two sars-cov-2 protein segments and α-synuclein alters its toxic oligomerization propensity differently
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9662073/
https://www.ncbi.nlm.nih.gov/pubmed/36354180
http://dx.doi.org/10.1021/acs.jpclett.2c02278
work_keys_str_mv AT mesiasvincestdollente moderatebindingbetweentwosarscov2proteinsegmentsandasynucleinaltersitstoxicoligomerizationpropensitydifferently
AT zhuhongni moderatebindingbetweentwosarscov2proteinsegmentsandasynucleinaltersitstoxicoligomerizationpropensitydifferently
AT tangxiao moderatebindingbetweentwosarscov2proteinsegmentsandasynucleinaltersitstoxicoligomerizationpropensitydifferently
AT daixin moderatebindingbetweentwosarscov2proteinsegmentsandasynucleinaltersitstoxicoligomerizationpropensitydifferently
AT liuwei moderatebindingbetweentwosarscov2proteinsegmentsandasynucleinaltersitstoxicoligomerizationpropensitydifferently
AT guoyusong moderatebindingbetweentwosarscov2proteinsegmentsandasynucleinaltersitstoxicoligomerizationpropensitydifferently
AT huangjinqing moderatebindingbetweentwosarscov2proteinsegmentsandasynucleinaltersitstoxicoligomerizationpropensitydifferently